Real World Evidence Solutions Market by Component (Data Sets and Services), by Therapeutic Area (Oncology, Cardiovascular Disease, Neurology, Immunology, and Others), and by End-Users (Pharmaceutical and Medical Device Companies, Healthcare Payers, Healthcare Providers, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2026

Global real world evidence solutions market expected to generate revenue of around USD 1,954.00 million by end of 2026, growing at a CAGR of around 13.8% between 2018 and 2026. The scenario of data collection is changing day by day. The demographic development and profile together with rising treatment potential leads to a lot of challenges to augment the productivity of healthcare.

Request Brochure Request Discount

17-Sep-2018 | Number of pages: 110 | Report Code: ZMR-3365 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the real world evidence solutions market on a global and regional level. The study provides historic data for 2016 and 2017 along with a forecast from 2018 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the real world evidence solutions market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the real world evidence solutions market on a global level.

In order to give the users of this report a comprehensive view of the real world evidence solutions market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein component, therapeutic areas, and end-user segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Real World Evidence Solutions

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, technology and regional expansion of major participants involved in the market on global and regional basis. Moreover, the study covers price trend analysis, component portfolio of various companies according to region.

The study provides a decisive view of the real world evidence solutions market by segmenting the market based on component, therapeutic areas, end-users, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2026. Based on component, the market is segmented into data set and services. The data set segment is further sub-segmented into clinical setting data, claims data, pharmacy data, and patient powered data. On the basis of the therapeutic area, the global market is segmented into oncology, cardiovascular disease, neurology, immunology, and others. Based on end-users, the market is segmented as pharmaceutical and medical device companies, healthcare payers, healthcare providers, and others. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further division into major countries including the U.S., Rest of North America, U.K., Germany, France, Italy, Spain, Rest of Europe, China, Japan, India, southeast Asia, Rest of Asia Pacific, Brazil, Rest of Latin America, GCC Countries, South Africa and Rest of the Middle East and Africa. This segmentation includes demand for real world evidence solutions market based on individual component, therapeutic areas, and end-user in all the regions and countries.

The report also includes detailed profiles of end players such as IQVIA, International Business Machines Corporation, ICON, PAREXEL, Pharmaceutical Product Development, Optum, Cognizant, Oracle, SAS, Syneos Health, Clinigen Group, Palantir Technologies, and Flatiron Health, among others.

This report segments the global real world evidence solutions market as follows:

Global Real World Evidence Solutions Market: Component Segment Analysis

  • Data Sets  
    • Clinical Setting Data
    • Claims Data
    • Pharmacy Data
    • Patient Powered Data
  • Services 

Global Real World Evidence Solutions Market: Therapeutic Area Segment Analysis

  • Oncology
  • Cardiovascular Disease
  • Neurology
  • Immunology
  • Others Therapeutic Areas

Global Real World Evidence Solutions Market: End-user Segment Analysis

  • Pharmaceutical and Medical Device Companies
  • Healthcare Payers
  • Healthcare Providers
  • Others

Global Real World Evidence Solutions Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

U.S. Healthcare Transportation Services Market By Type (Medical Transportation (Medical End-Users, Incubator Transport, Mobile Treatment Facilities, and Patient Transport) and Non-Medical Transportation (Mailroom Services, Event Covers and Others)) and By End-Users (Private Paying Customers, Hospitals, Medical Centers, Nursing Care Facilities, and Airport Shuttle): U.S. Industry Perspective, Comprehensive Analysis, and Forecast, 2017 – 2026

Oct-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3455 | Report Format:

The report analyzes and forecasts the healthcare transportation services market in the U.S. on the country level. The study offers past data for 2016 and 2017 along with forecast from 2018 to 2026 based on revenue (USD Billion). Assessment of healthcare transportation services market dynamics give...Read More

Peptide Therapeutics Market by Route of Administration (Parenteral, Oral, and Others), by Type (Innovative and Generic), by Type of Manufacturers (In-house and Outsourced), by Type of Molecule (Vasopressin, Somatostatin, Calcitonin, Immunopeptide, Natriuretic, and Others), by Technology (Liquid Phase, Solid Phase, and Hybrid Phase), and by Application (Cancer, Cardiovascular Disease, Metabolic Disease, Respiratory Disease, Infectious Disease, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024

Oct-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3439 | Report Format:

The report covers forecast and analysis for the peptide therapeutics market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the peptide therape...Read More

Cognitive and Memory Enhancer Drugs Market by Drug Type (Aricept, Razadyne, Namenda, Exelon, Provigil, Ritalin, Adderall, and others) and Application (Disease Treatment, Academic Performance, Athletic Performance and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 –2024

Oct-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3429 | Report Format:

The report covers forecast and analysis for the cognitive and memory enhancer drugs market on a global and regional level. The study provides historical data from 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints ...Read More

Connected Healthcare Market by Function (Telemedicine, Home Monitoring, Assisted Living, and Clinical Monitoring), by Type (e-Prescription, mHealth Services, and mHealth Devices), and Application (Diagnosis & Treatment, Monitoring Applications, Education & Awareness, Wellness & Prevention, Healthcare Management, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Oct-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3417 | Report Format:

The report covers forecast and analysis for the connected healthcare market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the connected healthcare ma...Read More

Kidney Stones Management Market by Diagnostics (Computed Tomography Scan, Abdominal X-ray, Ultrasound, Intravenous Pyelography, Abdominal MRI, and Others), by Type (Calcium Oxalate, Uric Acid, Calcium Phosphate, Cysteine, and Struvite), and by Treatment (Extracorporeal shock wave lithotripsy, Percutaneous Nephrolithotomy, Ureteroscopy, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Oct-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3412 | Report Format:

The report covers forecast and analysis for the kidney stones management market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the kidney stones manag...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.